Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pneumococcal iron acquisition A (PiaA) is a surface-exposed lipoprotein in Streptococcus pneumoniae that serves as the substrate-binding protein for the PiaABCD ABC transporter system (UniProt P0A4G4). It plays a critical role in bacterial survival by facilitating the uptake of iron from host sources such as heme and hemoglobin (Brown et al., 2001, PMID: 11443083). Since iron is an essential nutrient for bacterial growth and metabolism, PiaA is a key determinant of pneumococcal virulence during systemic infections like pneumonia and meningitis (Whalan et al., 2006, PMID: 16434447). The protein is highly conserved across nearly all pneumococcal serotypes, making it an attractive target for the development of next-generation protein-based vaccines (Jomaa et al., 2005, PMID: 15659714). Immunization with PiaA has been shown to elicit protective immune responses in animal models, often working synergistically with other iron-acquisition proteins like PiuA (Romero-Steiner et al., 2003, PMID: 12644290). By targeting PiaA, therapeutic strategies aim to disrupt the pathogen's ability to scavenge iron, thereby inhibiting its proliferation and reducing its pathogenic potential. This approach is particularly relevant for addressing antibiotic-resistant strains of S. pneumoniae.
Vaccine-induced antibody production leading to opsonophagocytosis or functional neutralization of iron transport.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pneumococcal iron acquisition A (PiaA) (PiaA).